US based 3M is in talks with Indian pharma companies to license tech technologies
US-based $23-billion diversified technology firm 3M is in talks with top domestic pharma companies to licence drug delivery technologies.
TRANS-DERMAL-DRUG-DELIVERY-SOLUTIONS
US based 3M is in talks with Indian pharma companies to license tech technologies
US-based $23-billion diversified technology firm 3M is in talks with top domestic pharma companies to licence drug delivery technologies.
